Literature DB >> 20306551

Towards more consistent use of generic quality-of-life instruments.

Mattias Neyt.   

Abstract

Mesh：

Year:  2010        PMID： 20306551     DOI： 10.2165/11530980-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  8 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 2.  Economics notes: measuring outcomes in economic evaluations.

Authors:  D Torgerson; J Raftery
Journal:  BMJ       Date:  1999-05-22

Review 3.  The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art.

Authors:  M Deverill; J Brazier; C Green; A Booth
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 4.  Utility measurement in healthcare: the things I never got to.

Authors:  George W Torrance
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 5.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Constructing health state preference values from descriptive quality of life outcomes: mission impossible?

Authors:  J V Chancellor; D Coyle; M F Drummond
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

7.  Resource allocation decisions in health care: a role for quality of life assessments?

Authors:  M F Drummond
Journal:  J Chronic Dis       Date:  1987

8.  Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.

Authors:  Gregorio Brevetti; Roberta Annecchini; Roxanna Bucur
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
  8 in total
  1 in total

Review 1.  Using QALYs in cancer: a review of the methodological limitations.

Authors:  Martina Garau; Koonal K Shah; Anne R Mason; Qing Wang; Adrian Towse; Michael F Drummond
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.